{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:40:15Z","timestamp":1793385615412,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T00:00:00Z","timestamp":1541808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004282","name":"Evelyn Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004282","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1111\/ajt.15177","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T09:23:07Z","timestamp":1541841787000},"page":"1708-1719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":220,"title":["HLA-DR\/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity"],"prefix":"10.1016","volume":"19","author":[{"given":"Chris","family":"Wiebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Kosmoliaptsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Pochinco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian W.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Birk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Karpinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Nickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1111\/ajt.15177_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ajt.14635","article-title":"Meeting report: FDA public meeting on patient-focused drug development and medication adherence in solid organ transplant patients","volume":"18","author":"Ettenger","year":"2018","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15177_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/tri.13079","article-title":"Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice","volume":"31","author":"Dharnidharka","year":"2017","journal-title":"Transpl Int."},{"issue":"12","key":"10.1111\/ajt.15177_bib3","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1681\/ASN.2014121234","article-title":"Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients","volume":"26","author":"Hricik","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"10.1111\/ajt.15177_bib4","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1111\/ajt.13946","article-title":"Failure of calcineurin inhibitor (tacrolimus) weaning randomized trial in long-term stable kidney transplant recipients","volume":"16","author":"Dugast","year":"2016","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15177_bib5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/ajt.14109","article-title":"Reduction of extended-release tacrolimus dose in low-immunological-risk kidney transplant recipients increases risk of rejection and appearance of donor-specific antibodies: a randomized study","volume":"17","author":"Gatault","year":"2017","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15177_bib6","first-page":"462","article-title":"Sensitization in Transplantation: Assessment of Risk (STAR) 2017 working group meeting report","volume":"15","author":"Tambur","year":"2018","journal-title":"Am J Transplant."},{"issue":"suppl. 3","key":"10.1111\/ajt.15177_bib7","first-page":"S1","article-title":"Special issue: KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15177_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation."},{"issue":"11","key":"10.1111\/ajt.15177_bib9","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1681\/ASN.2017030287","article-title":"Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development","volume":"28","author":"Wiebe","year":"2017","journal-title":"Am Soc Nephrol."},{"issue":"12","key":"10.1111\/ajt.15177_bib10","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-a strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.15177_bib11","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15177_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.humimm.2006.10.003","article-title":"HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ and HLA-DP","volume":"68","author":"Duquesnoy","year":"2007","journal-title":"Hum Immunol."},{"issue":"4","key":"10.1111\/ajt.15177_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/ajt.13582","article-title":"Developing new immunosuppression for the next generation of transplant recipients: the path forward","volume":"16","author":"Stegall","year":"2016","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.15177_bib14","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/TP.0000000000001648","article-title":"Clinical trials for immunosuppression in transplantation: the case for reform and change in direction","volume":"101","author":"O\u02bcConnell","year":"2017","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15177_bib15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001651","article-title":"Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) group","volume":"101","author":"Neuberger","year":"2017","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15177_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15177_bib17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.15177_bib18","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/j.1600-6143.2006.01521.x","article-title":"Transplanting the highly sensitized patient: the emory algorithm","volume":"6","author":"Bray","year":"2006","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15177_bib19","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/ajt.14247","article-title":"Donor specificity but not broadness of sensitization is associated with antibody-mediated rejection and graft loss in renal allograft recipients","volume":"17","author":"Wehmeier","year":"2017","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15177_bib20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/TP.0000000000001115","article-title":"The risk of transplant failure with HLA mismatch in first adult kidney allografts from deceased donors","volume":"100","author":"Williams","year":"2016","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15177_bib21","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.14746","article-title":"Carpe diem-time to transition from empiric to precision medicine in kidney transplantation","volume":"18","author":"Wiebe","year":"2018","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.15177_bib22","first-page":"1604","article-title":"Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: na\u00efve abdominal transplant organ subgroup focus on kidney transplantation","volume":"18","author":"Mannon","year":"2018","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15177_bib23","first-page":"432","article-title":"Renal homotransplantation in identical twins","volume":"6","author":"Harrison","year":"1956","journal-title":"Surg Forum."},{"issue":"11","key":"10.1111\/ajt.15177_bib24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.humimm.2011.07.303","article-title":"High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes","volume":"72","author":"Kosmoliaptsis","year":"2011","journal-title":"Hum Immunol."},{"key":"10.1111\/ajt.15177_bib25","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/TP.0000000000002117","article-title":"A comparison of HLA molecular mismatch methods to determine HLA immunogenicity","volume":"102","author":"Wiebe","year":"2018","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15177_bib26","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/ajt.13707","article-title":"Alloantibody responses after renal transplant failure can be better predicted by donor-recipient HLA amino acid sequence and physicochemical disparities than conventional HLA matching","volume":"16","author":"Kosmoliaptsis","year":"2016","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15177_bib27","series-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","year":"2016"},{"issue":"8","key":"10.1111\/ajt.15177_bib28","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/ajt.13341","article-title":"The synergistic effect of class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15177_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ajt.12968","article-title":"HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study","volume":"15","author":"Sapir-Pichhadze","year":"2015","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15177_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2013.218","article-title":"Biomarker enrichment strategies: matching trial design to biomarker credentials","volume":"11","author":"Freidlin","year":"2014","journal-title":"Nat Rev Clin Oncol."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15177","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15177","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15177","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:24:30Z","timestamp":1761629070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522091158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1600613522091158"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15177","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-DR\/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}